Science-backed SurityPro CBD soft chews and
well drops are formulated to deliver the most CBD per
body weight on the market
ATLANTA, Feb. 4, 2021 /PRNewswire/ - Canopy Animal Health
– a division of one of the world's leading cannabis companies,
Canopy Growth Corporation (TSX: WEED, NASDAQ:CGC) – announced the
launch of a new line of science-backed CBD products for dogs under
the brand name SurityPro™. Leading scientists at Canopy Animal
Health developed this new generation of advanced pet specialty CBD
products for dogs to support calm behavior, joint health and
flexibility, healthy aging, and overall physical and mental
well-being in dogs.
The SurityPro portfolio is scientifically-formulated to deliver
carefully controlled CBD content for customized daily use in dogs
of all sizes. All SurityPro CBD Pet products carry the National
Animal Supplement Council (NASC) quality seal, denoting strict
adherence to manufacturing, labeling, testing and marketing
guidelines. The products also contain no corn, soy, artificial
flavors, colors or preservatives.
"After four years of continuing research, testing and
collaborating with the veterinary community and regulatory
authorities, our new products meet the most rigorous quality
standards," said Robert Menardi,
DVM, Director of Veterinary Educational and Technical Services at
Canopy Animal Health. "We are the industry leader in pet CBD
research with more than 32 completed studies into the potential use
of cannabinoids in pet health. We're confident in the science
behind our products and committed to making CBD soft chews and oils
that pet owners can trust and dogs will love."
The new dog CBD products, which are formulated to deliver the
highest amount of CBD per body weight available, include five
formulas with different intended benefits:
- SurityPro Calm (Smoky Bacon flavor, 30 count) with
L-Theanine
-
- Small dogs (5-25 pounds), 11 mg CBD/chew for $32.99
- Medium dogs (26-50 pounds), 22 mg CBD/chew for $34.99
- Large dogs (51-130 pounds), 50 mg CBD/chew for $36.99
- SurityPro Active (Smoky Bacon flavor, 30 count)
with Boswellia
-
- Small dogs (5-25 pounds), 14 mg CBD/chew for $32.99
- Medium dogs (26-50 pounds), 28 mg CBD/chew for $34.99
- Large dogs (51-130 pounds), 54 mg CBD/chew for $36.99
- SurityPro Multi (Smoky Bacon flavor, 30 count) with
L-Theanine, Boswellia and Krill Oil
-
- Small dogs (5-25 pounds), 15 mg CBD/chew for $32.99
- Medium dogs (26-50 pounds), 29 mg CBD/chew for $34.99
- Large dogs (51-130 pounds), 57 mg CBD/chew for $36.99
- SurityPro Healthy Aging (Smoky Bacon flavor, 30 count)
with Green-Lipped Mussel, Lutein and Zeaxanthin
-
- Small dogs (5-25 pounds), 13 mg CBD/chew for $32.99
- Medium dogs (26-50 pounds), 25 mg CBD/chew for $34.99
- Large dogs (51-130 pounds), 48 mg CBD/chew for $36.99
- SurityPro Well Drops (Unflavored, Chicken, Bacon
and Creamy Peanut Butter flavors, 750 mg CBD/bottle) for
$39.99
In addition to SurityPro, Canopy Animal Health partnered with
Martha Stewart to launch another
line of CBD products for pets that includes CBD oil drops and
savory soft-baked chews for dogs formulated with premium
hemp-derived, broad-spectrum CBD. The flavors, created by
Martha Stewart, include chicken and
cranberry, chicken and blueberry, as well as chicken-flavored
wellness drops.
To purchase SurityPro and Martha Stewart CBD pet products,
visit shopcanopy.com. SurityPro will also be available
for purchase at Direct CBD Online -
https://www.directcbdonline.com.
About Canopy Animal Health
Canopy Animal Health is a
wholly owned subsidiary of Canopy Growth (TSX: WEED, NASDAQ: CGC),
committed to improving the lives of companion animals through
tested and scientifically proven cannabinoid and CBD products. With
the industry's largest financial outlay for research and
development, Canopy Animal Health is working to develop products
that solve real-world pet issues as defined by practicing
veterinarians. For more information, please visit
canopyanimalhealth.com.
About Canopy Growth Corporation
Canopy Growth
(TSX:WEED, NASDAQ:CGC) is a world-leading diversified cannabis and
cannabinoid-based consumer product company, driven by a passion to
improve lives, end prohibition, and strengthen communities by
unleashing the full potential of cannabis. Leveraging consumer
insights and innovation, we offer product varieties in high quality
dried flower, oil, softgel capsule, infused beverage, edible, and
topical formats, as well as vaporizer devices by Canopy Growth and
industry-leader Storz & Bickel. Our global medical brand,
Spectrum Therapeutics, sells a range of full-spectrum products
using its color-coded classification system and is a market leader
in both Canada and Germany. Through our award-winning Tweed and
Tokyo Smoke banners, we reach our adult-use consumers and have
built a loyal following by focusing on top quality products and
meaningful customer relationships. Canopy Growth has entered into
the health and wellness consumer space in key markets including
Canada, the United States, and Europe through BioSteel sports nutrition, and
This Works skin and sleep solutions; and has introduced additional
federally-permissible CBD products to the
United States through our First & Free and Martha
Stewart CBD brands. Canopy Growth has an established partnership
with Fortune 500 alcohol leader Constellation Brands. For more
information visit www.canopygrowth.com.
Notice Regarding Forward Looking Statements
This press release contains "forward-looking statements" and
"forward-looking information" within the meaning of applicable U.S.
and Canadian securities laws (collectively, "forward-looking
statements"), which involve certain known and unknown risks and
uncertainties. Forward-looking statements predict or describe our
future operations, business plans, business and investment
strategies and the performance of our investments. These
forward-looking statements are generally identified by their use of
such terms and phrases as "intend," "goal," "strategy," "estimate,"
"expect," "project," "projections," "forecasts," "plans," "seeks,"
"anticipates," "potential," "proposed," "will," "should," "could,"
"would," "may," "likely," "designed to," "foreseeable future,"
"believe," "scheduled" and other similar expressions. You are
cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date the statement was made.
Forward–looking statements are necessarily based upon a number of
estimates and assumptions that, while considered reasonable by
management, are inherently subject to significant business,
economic and competitive risks, financial results, results,
performance or achievements expressed or implied by those
forward–looking statements and the forward-looking statements are
not guarantees of future performance. Accordingly, there are or
will be important factors that could cause actual outcomes or
results to differ materially from those indicated in these
statements. A discussion of some of the material factors applicable
to Canopy Growth can be found under the section entitled "Risk
Factors" in Canopy Growth's Annual Report on Form 10-K for the year
ended March 31, 2020, filed with the
Securities and Exchange Commission and with applicable Canadian
securities regulators, as such factors may be further updated from
time to time in its periodic filings with the Securities and
Exchange Commission and with applicable Canadian securities
regulators, which can be accessed at www.sec.gov/edgar and
www.sedar.com, respectively. These factors should not be construed
as exhaustive and should be read in conjunction with the other
cautionary statements that are included in this press release and
in the filings. Any forward–looking statement included in this
press release is made as of the date of this press release and,
except as required by law, Canopy Growth disclaims any obligation
to update or revise any forward-looking statement. Readers are
cautioned not to put undue reliance on any forward-looking
statement. Forward-looking statements contained in this press
release are expressly qualified by this cautionary statement.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/canopy-animal-health-launches-suritypro---a-new-generation-of-cbd-products-for-dogs-301221864.html
SOURCE Canopy Growth Corporation